tirzepatide is the same as zepbound Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity Zepbound: New FDA-Approved Weight Loss
Description
GLP-1 agonists In the late 1980s a group of scientists identified the first GLP-1 agonist (Exendin-4) in animals
Activating both receptors can improve insulin secretion, enhance fat metabolism and amplify appetite suppression
It works by targeting both GLP-1 and GIP receptors, making it highly effective for weight reduction
Fast Shipping: Medication is dispatched quickly and arrives in just days
